As per the Thursday release, Endo will be folded into Mallinckrodt, which will then continue as the holding entity for the ...

Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. Terlipressin – now given ...

Philadelphia-based Endo sold its international pharma unit to Knight Therapeutics this week for up to $99 million, while ...

The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.

Acute kidney injury (AKI) is estimated to occur in up to 50% of patients with liver cirrhosis and is associated with increased morbidity and a high risk of short-term and long-term mortality.1 ...

and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive ...

There were four deaths in the PSC-IBD group from IBD related causes (all from metastatic carcinoma) and five deaths from PSC related causes (decompensated liver failure, cholangiocarcinoma, and ...